Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clene (CLNN) Cash & Equivalents (2020 - 2025)

Clene has reported Cash & Equivalents over the past 6 years, most recently at $5.2 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $5.2 million for Q4 2025, down 57.31% from a year ago — trailing twelve months through Dec 2025 was $5.2 million (down 57.31% YoY), and the annual figure for FY2025 was $5.2 million, down 57.31%.
  • Cash & Equivalents for Q4 2025 was $5.2 million at Clene, down from $7.9 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for CLNN hit a ceiling of $63.0 million in Q2 2021 and a floor of $5.2 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $18.4 million (2022), compared with a mean of $25.3 million.
  • Biggest five-year swings in Cash & Equivalents: surged 814.6% in 2021 and later plummeted 88.49% in 2022.
  • Clene's Cash & Equivalents stood at $50.3 million in 2021, then plummeted by 63.55% to $18.3 million in 2022, then soared by 57.22% to $28.8 million in 2023, then crashed by 57.83% to $12.2 million in 2024, then tumbled by 57.31% to $5.2 million in 2025.
  • The last three reported values for Cash & Equivalents were $5.2 million (Q4 2025), $7.9 million (Q3 2025), and $7.3 million (Q2 2025) per Business Quant data.